Cellectis

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Cellectis and buy or sell other stocks, ETFs, and their options commission-free!

About CLLS

Cellectis SA operates as a clinical stage biotechnological company, which engages in gene-editing platform to develop cell and gene therapies. The company was founded by David J. 

CEO
André Choulika
CEOAndré Choulika
Employees
222
Employees222
Headquarters
Paris, Ile-de-France
HeadquartersParis, Ile-de-France
Founded
2000
Founded2000
Employees
222
Employees222

CLLS Key Statistics

Market cap
251.47M
Market cap251.47M
Price-Earnings ratio
-5.89
Price-Earnings ratio-5.89
Dividend yield
—
Dividend yield—
Average volume
142.92K
Average volume142.92K
High today
$3.56
High today$3.56
Low today
$3.28
Low today$3.28
Open price
$3.43
Open price$3.43
Volume
184.51K
Volume184.51K
52 Week high
$3.76
52 Week high$3.76
52 Week low
$1.10
52 Week low$1.10

CLLS News

Simply Wall St 5d
Subdued Growth No Barrier To Cellectis S.A. With Shares Advancing 26% - simplywall.st

...

Subdued Growth No Barrier To Cellectis S.A. With Shares Advancing 26% - simplywall.st

Analyst ratings

75%

of 8 ratings
Buy
75%
Hold
25%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.